# Corning Incorporated  Share Price Target ‘$38.73’, now .8% Upside Potential

- Link: https://www.directorstalkinterviews.com/corning-incorporated-share-price-target-38.73-now.8-upside-potential/4121164260
- Published: 2024-07-08T12:05:28+01:00
- Author: Charlotte Edwards

**Corning Incorporated** which can be found using ticker (GLW) have now 13 analysts
in total covering the stock. The consensus rating is pointing to ‘buy’. The range
between the high target price and low target price is between $45.00 and $29.00 
calculating the average target share price we see $38.73. (at the time of writing).
Given that the stocks previous close was at $38.42 this indicates there is a potential
upside of .8%. The 50 day MA is $36.25 and the 200 day moving average is $31.88.
The company has a market capitalization of 32.93B. The current stock price for Microsoft
Corporation is currently $38.44 USD

 The potential market cap would be $33,194,124,301 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 53.39, revenue per share of $14.57
and a 2.85% return on assets.

Corning Incorporated is a materials science technology and innovation company. The
Company operates through five segments: Optical Communications, Display Technologies,
Specialty Materials, Environmental Technologies and Life Sciences. The Optical Communications
segment manufactures carrier network and enterprise network components for the telecommunications
industry. The Display Technologies segment manufactures glass substrates for flat
panel liquid crystal displays and other high-performance display panels. Its Specialty
Materials segment is engaged in manufacturing products that provide material formulations
for glass, glass ceramics and fluoride crystals to meet demand for customer needs.
Its Environmental Technologies segment manufactures ceramic substrates and filters
for emission control systems. Its Life Sciences segment manufactures glass and plastic
labware, equipment, media, serum and reagents enabling workflow solutions for drug
discovery and bioproduction.

Share on: